English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionGlenmark Life Sciences keeps up growth outlook in spite of Red Sea turmoil

    Glenmark Life Sciences keeps up growth outlook in spite of Red Sea turmoil

    Sales in March 2024 quarter declined by 13.6 percent amid shipment delays and logistics challenges

    R. Sree Ram
    April 29, 2024 / 09:25 IST
    Glenmark Life Sciences keeps up growth outlook in spite of Red Sea turmoil

    Logistics

    • PRO Panorama

      Moneycontrol Pro Panorama | Dots, plots, and tequila shots

      Sep 19, 2025 / 02:55 PM IST

      In Moneycontrol Pro Panorama September 19 edition: Kerala debate rekindles conversion topic, global regulations force India to ret...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts